F8 and hemophilia A: In persons with severe hemophilia A (PWSHA), an intensive treatment with factor VIII (FVIII) concentrate is required together with a postoperative close monitoring of circulating FVIII to maintain protective levels for bleeding, while avoiding excessive levels with inherent thrombotic risk.